These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9198152)

  • 1. Oxidized lipids in atherogenesis: formation, destruction and action.
    Berliner J; Leitinger N; Watson A; Huber J; Fogelman A; Navab M
    Thromb Haemost; 1997 Jul; 78(1):195-9. PubMed ID: 9198152
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein oxidation.
    Iuliano L; Micheletta F; Violi F
    Ital Heart J; 2001 Dec; 2(12):867-72. PubMed ID: 11838329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
    Navab M; Ananthramaiah GM; Reddy ST; Van Lenten BJ; Ansell BJ; Fonarow GC; Vahabzadeh K; Hama S; Hough G; Kamranpour N; Berliner JA; Lusis AJ; Fogelman AM
    J Lipid Res; 2004 Jun; 45(6):993-1007. PubMed ID: 15060092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized LDL and atherogenesis.
    Ylä-Herttuala S
    Ann N Y Acad Sci; 1999 Jun; 874():134-7. PubMed ID: 10415527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Processes of modification of lipoproteins. Physiological and pathogenetical role of modified lipoproteins].
    Belova LA; Ogloblina OG; Belov AA; Kukharchuk VV
    Vopr Med Khim; 2000; 46(1):8-21. PubMed ID: 10802881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial scavenger receptors.
    Adachi H; Tsujimoto M
    Prog Lipid Res; 2006 Sep; 45(5):379-404. PubMed ID: 16712941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of EC-SOD does not promote atherogenesis in mice: have we lost yet another player?
    Nilsson J
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1387-8. PubMed ID: 11557660
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endothelial dysfunction by oxidized LDL].
    Kume N
    Nihon Ronen Igakkai Zasshi; 2000 May; 37(5):360-2. PubMed ID: 10936924
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidized LDL in atherosclerosis.
    Witztum JL
    Adv Exp Med Biol; 1991; 285():353-65. PubMed ID: 1858567
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
    Moriel P; Okawabata FS; Abdalla DS
    IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxidized LDL membrane receptors: their role in atherogenesis].
    Laporte F
    Nephrologie; 2000; 21(7):327-8. PubMed ID: 11200601
    [No Abstract]   [Full Text] [Related]  

  • 15. Poloxamer 407-induced atherosclerosis in mice appears to be due to lipid derangements and not due to its direct effects on endothelial cells and macrophages.
    Johnston TP; Li Y; Jamal AS; Stechschulte DJ; Dileepan KN
    Mediators Inflamm; 2003 Jun; 12(3):147-55. PubMed ID: 12857598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
    Shaw PX
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis.
    Paolicchi A; Minotti G; Tonarelli P; Tongiani R; De Cesare D; Mezzetti A; Dominici S; Comporti M; Pompella A
    J Investig Med; 1999 Mar; 47(3):151-60. PubMed ID: 10198571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of phospholipid oxidation products in atherogenesis.
    Berliner JA; Subbanagounder G; Leitinger N; Watson AD; Vora D
    Trends Cardiovasc Med; 2001; 11(3-4):142-7. PubMed ID: 11686004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of oxidatively modified lipids in atherosclerotic lesions of human aortas.
    Belkner J; Wiesner R; Kühn H
    Agents Actions Suppl; 1992; 37():78-84. PubMed ID: 1632313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.